1. Home
  2. BCRX vs AXGN Comparison

BCRX vs AXGN Comparison

Compare BCRX & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$9.53

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$41.37

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
AXGN
Founded
1986
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.2B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
BCRX
AXGN
Price
$9.53
$41.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
9
Target Price
$20.82
$42.33
AVG Volume (30 Days)
4.2M
1.2M
Earning Date
05-06-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
381.40
N/A
EPS
N/A
N/A
Revenue
$25,186,000.00
$225,208,000.00
Revenue This Year
N/A
$20.57
Revenue Next Year
$12.55
$16.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.21
52 Week Low
$6.00
$12.39
52 Week High
$11.22
$46.95

Technical Indicators

Market Signals
Indicator
BCRX
AXGN
Relative Strength Index (RSI) 50.19 57.17
Support Level $8.80 $29.48
Resistance Level $9.90 $44.83
Average True Range (ATR) 0.36 2.26
MACD -0.05 0.20
Stochastic Oscillator 34.75 62.31

Price Performance

Historical Comparison
BCRX
AXGN

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

Share on Social Networks: